Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Surface antigens of Neisseria meningitidis encompass the structurally and functionally diverse molecules present on the bacterial outer membrane and capsule, including capsular polysaccharides, lipooligosaccharide, and numerous outer membrane proteins such as porins (PorA, PorB), adhesins (Opa, Opc, NadA, NHBA, fHBP), and autotransporters. These antigens collectively facilitate the bacterium’s immune evasion, survival in the host, and ability to cause severe invasive disease (meningitis, sepsis). Many are under strong selective pressure from host immunity, undergo phase and antigenic variation, and are the major determinants of serogrouping and vaccine efficacy. Some, such as the polysaccharide capsule, are highly immunogenic and form the basis for classification and vaccine targets, while others (e.g., OMPs and adhesins) contribute to host cell attachment and colonization.
Vaccine-induced antibody binding and complement activation resulting in bactericidal killing Antibodies blocking adherence and invasion
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Surface antigens of Neisseria meningitidis.